Español
At OLIGOFASTX we are working to achieve solutions that improve the quality of life of patients affected by rare diseases, and for this we use all the power of technology, knowledge and the expertise from our partners. Like any other public or private entity, all our developments are subject to the different drug authorization processes […]
Author Archives: oligofastx
International Biotechnology Day 2024, Technology
The evolution of knowledge about RNA: from its discovery to the present day
02
Aug
Aug
RNA is an essential molecule for life, but its discovery and understanding has been a decades-long process. In this article, we will explore the evolution of knowledge about RNA from its discovery to the present day and how it has revolutionised our understanding of molecular biology and genetics. Introduction: What is RNA? Ribonucleic acid (RNA) […]
27
Jul
Jul
In this article, practical advice for parents of children affected by rare diseases will be presented. It will address various situations that may arise in everyday life, with the aim of providing useful tools to deal with them effectively. We hope that this information will be of great help to families in this situation. What […]
Technology
RNA Bibliography: a selection of the most influential publications in the field of biotechnology
13
Jul
Jul
RNA Bibliography: a selection of the most influential publications in the field of biotechnology In the field of biotechnology, RNA research is revolutionising the biomedical sector. From OLIGOFASTX we share an essential scientific bibliographic selection because the knowledge embodied in the publications is a reference for professionals. There is much more, but the selection of […]
Noticias
Innovation on the horizon: how big pharma investment is driving the development of oligonucleotide-based medicines
27
Jun
Jun
The mission of the OLIGOFATSX project is to develop oligonucleotide-based medicines to improve the quality of life of patients affected by rare diseases for which there is still no solution. The scientists involved in the project firmly believe that the future of personalised precision medicine lies in the successful combination of different technologies, including oligonucleotides; […]
International Biotechnology Day 2024, Technology
Enzymes: key molecules for the development of oligonucleotides
21
Jun
Jun
The OLIGOFASTX team is focused on the development of oligonucleotide-based therapies for certain rare diseases covering the whole cycle: from research to manufacturing and distribution of future new oligonucleotide-based drugs. To this end, the companies that make up the consortium are specialised in one area, which in combination provides a form of collaboration that allows […]
15
Jun
Jun
Clear and accessible science communication is essential to bring research advances closer to the general public and to foster understanding and interest in science. In this blog, we will explore the importance of effective communication in science and how it can improve the dissemination of research results. According to a study by Nature, only a […]
09
Jun
Jun
Nanotechnology is a field that has revolutionised the pharmaceutical industry. The ability to manipulate materials on a scale as tiny as nanometres allows scientists to create drug delivery systems that make them more effective in treating disease and safer for the patient. In fact, it is a strategic technology for OLIGOFASTX, a consortium which, although […]
Rare Diseases, Rare diseases
Hope for patients with Fuchs’ Endothelial Corneal Dystrophy: Innovations in treatment
31
May
May
Today we talk in our blog about another of the rare diseases that the OLIGOFASTX consortium is working on: Fuchs’ Corneal Endothelial Endothelial Dystrophy (FECD). This pathology affects approximately 4% of the population over 40 years of age, and much more women than men. Results from miRNA expression profiling in FECD endothelial cells demonstrates widespread […]
24
May
May
The European Week Against Cancer takes place from 25 to 31 May to raise awareness of cancer prevention, access to treatment and support for cancer survivors. From OLIGOFASTX we wanted to offer an overview of the current situation regarding the fight against this disease on the occasion of this week. In recent years, there have […]